Kenvue Inc. (NYSE:KVUE) Short Interest Update

Kenvue Inc. (NYSE:KVUE) saw a large decrease in short interest in the month of March. As of March 13th, there was short interest totaling 58,159,600 shares, a decrease of 12.9% from the February 26th total of 66,801,459 shares. Based on an average daily volume of 29,600,865 shares, the days-to-cover ratio is currently 2.0 days. Approximately 3.0% of the company’s shares are sold short.

Wall Street Analyst Weigh In

Several research analysts have issued reports on KVUE shares. Argus upgraded Kenvue to a “hold” rating in a research report on Friday, March 6th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Kenvue in a report on Friday, January 9th. UBS Group raised their price target on Kenvue from $17.00 to $19.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 18th. Canaccord Genuity Group boosted their price objective on Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a report on Wednesday, February 18th. Finally, Citigroup upped their price objective on Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a research report on Wednesday, February 18th. Three investment analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the stock. According to data from MarketBeat, Kenvue has an average rating of “Hold” and a consensus price target of $19.58.

Institutional Investors Weigh In On Kenvue

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Elyxium Wealth LLC bought a new position in shares of Kenvue during the 4th quarter worth $26,000. Physician Wealth Advisors Inc. increased its stake in shares of Kenvue by 67.5% during the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock valued at $26,000 after buying an additional 618 shares during the period. Cornerstone Planning Group LLC raised its holdings in shares of Kenvue by 705.2% in the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock valued at $25,000 after acquiring an additional 1,361 shares in the last quarter. NBT Bank N A NY raised its holdings in shares of Kenvue by 180.3% in the third quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after acquiring an additional 1,006 shares in the last quarter. Finally, Salomon & Ludwin LLC purchased a new stake in Kenvue in the third quarter worth about $25,000. 97.64% of the stock is owned by institutional investors.

Kenvue Price Performance

Kenvue stock opened at $17.39 on Thursday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.96 and a quick ratio of 0.68. The stock has a market cap of $33.32 billion, a price-to-earnings ratio of 22.58, a price-to-earnings-growth ratio of 3.91 and a beta of 0.61. The firm has a 50-day moving average of $18.01 and a two-hundred day moving average of $17.10. Kenvue has a 1 year low of $14.02 and a 1 year high of $25.17.

Kenvue (NYSE:KVUE) last issued its earnings results on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The business had revenue of $3.78 billion for the quarter, compared to analyst estimates of $3.68 billion. During the same period last year, the company posted $0.26 earnings per share. The company’s quarterly revenue was up 3.2% compared to the same quarter last year. On average, research analysts forecast that Kenvue will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were issued a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a yield of 4.8%. The ex-dividend date was Wednesday, February 11th. Kenvue’s dividend payout ratio (DPR) is presently 107.79%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.